{"AllianceGenome": "9177", "HGNC": "9177", "MIM": "174762", "_id": "5426", "_version": 1, "accession": {"genomic": ["AC131212.6", "AC135586.8", "AH008000.2", "AY176055.1", "AY273166.1", "AY405840.1", "CH471218.2", "CP068266.2", "HI574320.1", "NC_000012.12", "NC_060936.1", "NG_033840.1", "ON366697.1", "ON366698.1", "ON366699.1", "ON366700.1", "ON366701.1", "ON366702.1", "ON366703.1", "ON366704.1", "ON366705.1"], "protein": ["AAA15448.1", "AAA90924.1", "AAC19148.1", "AAD44690.1", "AAD44691.1", "AAD44692.1", "AAD45663.1", "AAH07599.1", "AAH21559.1", "AAH87613.1", "AAO46109.1", "AAP12650.1", "BAB15063.1", "BAG52636.1", "CAB45774.1", "CBX47649.1", "EAW54830.1", "EAW54831.1", "EAW54832.1", "EAW54833.1", "EAW54834.1", "NP_006222.2", "Q07864.5", "WCO08123.1", "WCO08124.1", "WCO08125.1", "WCO08126.1", "WCO08127.1", "WCO08128.1", "WCO08129.1", "WCO08130.1", "WCO08131.1", "XP_011533097.1", "XP_011533099.1", "XP_011533101.1", "XP_011533104.1", "XP_047284974.1", "XP_054228285.1", "XP_054228286.1", "XP_054228287.1", "XP_054228288.1", "XP_054228289.1"], "rna": ["AF128542.1", "AF128544.1", "AK025087.1", "AK093003.1", "AK128248.1", "AL080203.1", "BC007599.1", "BC011376.1", "BC021559.1", "BC087613.1", "BC144561.1", "BX647647.1", "CX782956.1", "L09561.1", "NM_006231.4", "S60080.1", "U49356.1", "XM_011534795.4", "XM_011534797.4", "XM_011534799.3", "XM_011534802.4", "XM_047429018.1", "XM_054372310.1", "XM_054372311.1", "XM_054372312.1", "XM_054372313.1", "XM_054372314.1", "XR_008488621.1", "XR_941395.3"], "translation": [{"protein": "AAH21559.1", "rna": "BC021559.1"}, {"protein": "AAH87613.1", "rna": "BC087613.1"}, {"protein": "NP_006222.2", "rna": "NM_006231.4"}, {"protein": "XP_054228287.1", "rna": "XM_054372312.1"}, {"protein": "XP_011533099.1", "rna": "XM_011534797.4"}, {"protein": "XP_054228289.1", "rna": "XM_054372314.1"}, {"protein": "BAG52636.1", "rna": "AK093003.1"}, {"protein": "AAA90924.1", "rna": "U49356.1"}, {"protein": "AAA15448.1", "rna": "S60080.1"}, {"protein": "XP_054228288.1", "rna": "XM_054372313.1"}, {"protein": "XP_054228286.1", "rna": "XM_054372311.1"}, {"protein": "BAB15063.1", "rna": "AK025087.1"}, {"protein": "XP_011533101.1", "rna": "XM_011534799.3"}, {"protein": "XP_011533097.1", "rna": "XM_011534795.4"}, {"protein": "CAB45774.1", "rna": "AL080203.1"}, {"protein": "XP_047284974.1", "rna": "XM_047429018.1"}, {"protein": "XP_054228285.1", "rna": "XM_054372310.1"}, {"protein": "AAH07599.1", "rna": "BC007599.1"}, {"protein": "AAD45663.1", "rna": "AF128542.1"}, {"protein": "AAC19148.1", "rna": "L09561.1"}, {"protein": "XP_011533104.1", "rna": "XM_011534802.4"}]}, "alias": ["CRCS12", "FILS", "IMAGEI", "POLE1"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2023-07-05T17:00:00.000Z", "disease_label": "POLE-related polyposis and colorectal cancer syndrome", "gcep": "Hereditary Cancer Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0100287", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8b5306f4-0422-42fc-9f67-2d9b263e4e1e-2023-07-05T170000.000Z", "sop": "SOP9"}}, "ec": "2.7.7.7", "ensembl": {"gene": "ENSG00000177084", "protein": ["ENSP00000322570", "ENSP00000442578", "ENSP00000445753", "ENSP00000479927", "ENSP00000480727", "ENSP00000500233", "ENSP00000500279", "ENSP00000500921", "ENSP00000514725", "ENSP00000514736", "ENSP00000514737", "ENSP00000514738"], "transcript": ["ENST00000320574", "ENST00000416953", "ENST00000434528", "ENST00000441786", "ENST00000503265", "ENST00000534922", "ENST00000535270", "ENST00000537064", "ENST00000538196", "ENST00000539215", "ENST00000539357", "ENST00000539618", "ENST00000540987", "ENST00000541627", "ENST00000544414", "ENST00000544870", "ENST00000545015", "ENST00000672002", "ENST00000672742", "ENST00000699981", "ENST00000699982", "ENST00000699983", "ENST00000699984", "ENST00000699985"], "translation": [{"protein": "ENSP00000322570", "rna": "ENST00000320574"}, {"protein": "ENSP00000479927", "rna": "ENST00000544870"}, {"protein": "ENSP00000500233", "rna": "ENST00000672002"}, {"protein": "ENSP00000514736", "rna": "ENST00000699982"}, {"protein": "ENSP00000514737", "rna": "ENST00000699983"}, {"protein": "ENSP00000500279", "rna": "ENST00000672742"}, {"protein": "ENSP00000514738", "rna": "ENST00000699984"}, {"protein": "ENSP00000442578", "rna": "ENST00000537064"}, {"protein": "ENSP00000500921", "rna": "ENST00000434528"}, {"protein": "ENSP00000445753", "rna": "ENST00000535270"}, {"protein": "ENSP00000480727", "rna": "ENST00000441786"}, {"protein": "ENSP00000514725", "rna": "ENST00000539215"}], "type_of_gene": "protein_coding"}, "entrezgene": "5426", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 87.0608165414, "exp_mis": 945.826418563, "exp_syn": 439.901776135, "lof_z": 5.10234063698405, "mis_z": 1.57175112774945, "mu_lof": 6.01550661051e-06, "mu_mis": 8.40447553056e-05, "mu_syn": 3.81873406838e-05, "n_lof": 39.0, "n_mis": 847.0, "n_syn": 412.0, "p_li": 1.00660603240353e-14, "p_null": 2.32523887287532e-08, "p_rec": 0.999999976747601, "syn_z": 0.824714873053927}, "bp": 6861, "cds_end": 133263901, "cds_start": 133201282, "n_exons": 49, "nonpsych": {"exp_lof": 77.8159374559, "exp_mis": 855.081700929, "exp_syn": 397.171060864, "lof_z": 4.87809031838241, "mis_z": 1.74353376310192, "mu_lof": 6.01550661051e-06, "mu_mis": 8.40447553056e-05, "mu_syn": 3.81873406838e-05, "n_lof": 34.0, "n_mis": 754.0, "n_syn": 372.0, "p_li": 1.38399319625815e-12, "p_null": 7.11196442245777e-08, "p_rec": 0.999999928878972, "syn_z": 0.795201005965952}, "nontcga": {"exp_lof": 80.0001858054, "exp_mis": 870.064599937, "exp_syn": 404.613889994, "lof_z": 5.18364550212545, "mis_z": 1.67321837354449, "mu_lof": 6.01550661051e-06, "mu_mis": 8.40447553056e-05, "mu_syn": 3.81873406838e-05, "n_lof": 33.0, "n_mis": 771.0, "n_syn": 385.0, "p_li": 1.48209121821197e-11, "p_null": 9.55696100988358e-09, "p_rec": 0.999999990428218, "syn_z": 0.617398908431554}, "transcript": "ENST00000320574.5"}, "exons": [{"cdsend": 132687315, "cdsstart": 132624696, "chr": "12", "position": [[132623761, 132624810], [132624904, 132624994], [132625644, 132625770], [132626116, 132626317], [132632314, 132632508], [132632663, 132632795], [132634185, 132634378], [132635891, 132636024], [132638013, 132638139], [132639124, 132639298], [132641646, 132641851], [132642176, 132642397], [132642505, 132642729], [132642819, 132642996], [132643223, 132643330], [132643406, 132643560], [132643836, 132643977], [132648928, 132649072], [132649305, 132649515], [132649676, 132649889], [132657135, 132657258], [132657348, 132657429], [132657867, 132657970], [132659294, 132659509], [132660968, 132661164], [132661526, 132661684], [132664003, 132664148], [132664369, 132664462], [132665301, 132665450], [132667502, 132667648], [132668355, 132668502], [132668634, 132668737], [132668810, 132668939], [132672214, 132672322], [132672626, 132672839], [132673163, 132673277], [132673574, 132673707], [132675397, 132675517], [132675734, 132675820], [132676093, 132676204], [132676545, 132676653], [132677362, 132677443], [132677577, 132677719], [132679496, 132679651], [132679953, 132680046], [132680177, 132680222], [132680606, 132680687], [132681137, 132681279], [132687253, 132687342]], "strand": -1, "transcript": "NM_006231", "txend": 132687342, "txstart": 132623761}], "exons_hg19": [{"cdsend": 133263901, "cdsstart": 133201282, "chr": "12", "position": [[133200347, 133201396], [133201490, 133201580], [133202230, 133202356], [133202702, 133202903], [133208900, 133209094], [133209249, 133209381], [133210771, 133210964], [133212477, 133212610], [133214599, 133214725], [133215710, 133215884], [133218232, 133218437], [133218762, 133218983], [133219091, 133219315], [133219405, 133219582], [133219809, 133219916], [133219992, 133220146], [133220422, 133220563], [133225514, 133225658], [133225891, 133226101], [133226262, 133226475], [133233721, 133233844], [133233934, 133234015], [133234453, 133234556], [133235880, 133236095], [133237554, 133237750], [133238112, 133238270], [133240589, 133240734], [133240955, 133241048], [133241887, 133242036], [133244088, 133244234], [133244941, 133245088], [133245220, 133245323], [133245396, 133245525], [133248800, 133248908], [133249212, 133249425], [133249749, 133249863], [133250160, 133250293], [133251983, 133252103], [133252320, 133252406], [133252679, 133252790], [133253131, 133253239], [133253948, 133254029], [133254163, 133254305], [133256082, 133256237], [133256539, 133256632], [133256763, 133256808], [133257192, 133257273], [133257723, 133257865], [133263839, 133263928]], "strand": -1, "transcript": "NM_006231", "txend": 133263928, "txstart": 133200347}], "generif": [{"pubmed": 11741962, "text": "It is hypothesized from these observations that pol epsilon and PCNA have separate but associated functions early in S phase and that pol epsilon participates with PCNA in DNA replication late in S phase."}, {"pubmed": 17855454, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17855454, "text": "SNPs associated with prognosis of lung cancer was mapped to POLE."}, {"pubmed": 19074885, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19129559, "text": "An AATT deletion in the 55 kDa small subunit DNA sequence of DNA polymerase epsilon is associated with breast cancer"}, {"pubmed": 19237606, "text": "Observational study of gene-disease association, gene-gene interaction, and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20226869, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20496165, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20503108, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20522537, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20574454, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20677014, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20677014, "text": "Statistical analysis indicated that six genes, NFATC2, SCP2, CACNA1C, TCRA, POLE, and FAM3D, were associated with narcolepsy."}, {"pubmed": 20826785, "text": "Stable interaction between the human proliferating cell nuclear antigen loader complex Ctf18-replication factor C (RFC) and DNA polymerase {epsilon} is mediated by the cohesion-specific subunits, Ctf18, Dcc1, and Ctf8."}, {"pubmed": 21157497, "text": "Mutation in the POLE gene that encodes p261 catalytic subunit of pol epsilon is the first found in human cells."}, {"pubmed": 21757740, "text": "In vitro gap-directed translesion DNA synthesis of an abasic site involving human DNA polymerases epsilon, lambda, and beta."}, {"pubmed": 22465957, "text": "Pol switches at replication-blocking lesions occur by the exchange of the Pol delta and Pol zeta catalytic subunits on a preassembled complex of accessory proteins retained on DNA during translesion DNA synthesis."}, {"pubmed": 22474384, "text": "Data show that using a 200-nt primed circular DNA substrate, the combined action of DNA polymerase epsilon and the Cdc45/Mcm2-7/GINS (CMG complex) leads to the formation of products >10 kb in length."}, {"pubmed": 22887995, "text": "Pol epsilon and Pol alpha/delta seem to pursue their functions at least in part independently in late S phase"}, {"pubmed": 23093410, "text": "Pol epsilon is a likely source of ribonucleotides in human genomic DNA."}, {"pubmed": 23230001, "text": "observed impairment in proliferation and G1- to S-phase progression in patients' T lymphocytes. Polepsilon1 depletion also impaired G1- to S-phase progression in B lymphocytes, chondrocytes, and osteoblasts."}, {"pubmed": 23263490, "text": "Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas."}, {"pubmed": 23447401, "text": "Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers."}, {"pubmed": 23528559, "text": "POLE and POLD1 mutations are associated with endometrial cancer."}, {"pubmed": 24020356, "text": "To catalyze leading-strand synthesis in vivo, Polepsilon likely interacts with its three smaller subunits and additional replication factors in order to assemble a replication complex and significantly enhance its polymerization processivity."}, {"pubmed": 24051051, "text": "Mutant Pol epsilon causes replication errors in vivo. In colorectal patients, the single allele mutations are microsatellite stable with a large increase in base pair substitutions, consistent with requirement of additional factors for tumor development."}, {"pubmed": 24472300, "text": "The POLE1 p.S297F mutation was frequent in Chinese ovarian endometrioid carcinoma."}, {"pubmed": 24501277, "text": "POLE and POLD1 mutations explain a fraction of familial CRC and polyposis. Sequencing the proofreading domains of POLE and POLD1 should be considered in routine genetic diagnostics."}, {"pubmed": 24509466, "text": "Germline mutations in the proofreading domains of 2 DNA polymerases (POLE and POLD1) have been associated with a dominantly inherited, highly penetrant syndrome of oligo adenomatous polyposis and early-age-of-diagnosis colorectal and endometrial cancer."}, {"pubmed": 24525744, "text": "Heterozygosity for the variant allele caused a strong mutator effect comparable with that of complete mismatch repair deficiency, providing an explanation for why loss of heterozygosity is not required for the development of Polepsilon-mutant human tumors."}, {"pubmed": 24788313, "text": "A new amino-acid substitution in POLE was identified resulting in a predisposition to a broad spectrum of tumours in addition to colorectal cancers."}, {"pubmed": 24844595, "text": "POLE exonuclease domain mutations occur in a subset of grade 3 endometrioid carcinomas and are associated with good clinical outcome."}, {"pubmed": 24861832, "text": "POLE mutations have been found in other tumor types, though at lower frequency, suggesting roles in tumorigenesis more broadly in different tissue types. [Review]"}, {"pubmed": 25184702, "text": "Hearing ability was strongly associated with DNA methylation levels in the promoter regions of several genes, including TCF25, FGFR1, and POLE."}, {"pubmed": 25224212, "text": "Somatic POLE exonuclease domain mutations are common in endometrioid endometrial cancer, are observed with equal frequency in tumors with microsatellite stability and those with microsatellite instability, and are not associated with survival."}, {"pubmed": 25228659, "text": "Data indicate that exonuclease domain of DNA polymerase epsilon (POLE-exo*) mutants generate a unique pattern of replication errors."}, {"pubmed": 25370038, "text": "None of the 1188 patients carried the POLD1 p.(Ser478Asn) variant. POLE germline variant carriers are also associated with a microsatellite instable colorectal cancer"}, {"pubmed": 25394778, "text": "the recognition of ultramutated endometrial carcinomas with POLE exonuclease domain mutation is important given their favorable outcome"}, {"pubmed": 25414327, "text": "The 3'-->5' exonuclease activity of hPol further enhances polymerization fidelity by an unprecedented 3.5 x 10(2) to 1.2 x 10(4)-fold."}, {"pubmed": 25529843, "text": "Data indicate that the polymerase (DNA directed), epsilon protein (POLE) mutation c.1270C>G;p.Leu424Val was detected in 1.5% (4/266) of all patients, 4% (3/77) of all familial cases and 7% (2/30) of familial polyposis cases."}, {"pubmed": 25684708, "text": "The kinetic parameters of the truncated catalytic subunit and holoenzyme of human DNA polymerase varepsilon are compared."}, {"pubmed": 25740784, "text": "Identified a genomically, histologically, and clinically distinct subgroup of high-grade gliomas that harbored somatic POLE mutations and carried an improved prognosis."}, {"pubmed": 25860647, "text": "A novel c.1373A>T (p.Tyr458Phe)POLE mutation associated with cancers of colon, pancreas, ovaries and small intestine."}, {"pubmed": 25878334, "text": "POLE proofreading-mutant endometrial cancers are characterized by a robust intratumoral T-cell response, which correlates with, and may be caused by an enrichment of antigenic neopeptides"}, {"pubmed": 25931171, "text": "POLE ultra-mutated-tumors are significantly more immunogenic when compared to POLE (-) tumors, in particular to the helper arm of the immune system."}, {"pubmed": 26133394, "text": "study of complete exonuclease domains of POLE and POLD1 in 529 families characterized by presence of familial or early-onset mismatch repair proficient colorectal cancer, and/or APC-negative and MUTYH-negative polyposis; results widen the phenotypic spectrum of the POLE/POLD1-associated syndrome and identify novel pathogenic variants"}, {"pubmed": 26166557, "text": "Missense point mutations in POLE gene is associated with Ovarian Endometrioid Carcinoma."}, {"pubmed": 26181000, "text": "Results show that that mutated POLE 1 are associated with high neoantigen loads and may be excellent candidates for PD-1-targeted immunotherapies."}, {"pubmed": 26251183, "text": "POLE mutations are associated with cutaneous melanoma."}, {"pubmed": 26271349, "text": "On the sequence, Escherichia coli oriC plasmid DNA, it was found hPold replicates DNA across the CCG repeats but hPole stalls at the CCG repeats even if the secondary structure is eliminated by a single stranded binding protein."}, {"pubmed": 26416160, "text": "POLE-mutated endometrial carcinomas are typically of high grade, with prominent lymphocytic infiltration, but they are not sufficiently distinctive to allow accurate diagnosis based on routine haematoxylin and eosin staining"}, {"pubmed": 26493165, "text": "Study identified a high penetrant duplication in the regulatory region of GREM1, predisposing to colorectal cancer (CRC) in a family with attenuated/ atypical polyposis. A POLE variant was also identified in a patient with early onset CRC."}, {"pubmed": 26648449, "text": "Germline or somatic variants in the POLE/POLD1 were identified in unresolved suspected Lynch syndrome cancers with mismatch repair defect."}, {"pubmed": 26748215, "text": "Mutations in POLE and POLD1 in south east Asia women with grade 3 endometrioid endometrial carcinomas are associated with improved recurrence free survival."}, {"pubmed": 26763250, "text": "POLE exonuclease domain mutations are prognostic markers associated with excellent outcomes for endometrial carcinoma patients."}, {"pubmed": 26937754, "text": "POLE mutations in tumors of women with grade 3 EEC are associated with a lower risk of recurrence and death, although not statistically significant because of high variability in these estimates."}, {"pubmed": 27235625, "text": "POLE1 is phosphorylated at serine-1940 after DNA damage and interacts with the iron-sulfur complex chaperones CIAO1 and MMS19."}, {"pubmed": 27244218, "text": "In colorectal cancers, mutations in the FBXW7 gene were more common in the younger cohort (27.5% vs 9.7%; P = .0022) as were mutations in the proofreading domain of polymerase epsilon catalytic subunit (POLE) (9.8% vs 1%; P = .0048)."}, {"pubmed": 27612425, "text": "Data show that the POLE mutation leading to hypermutation can accelerate cancer development."}, {"pubmed": 27683556, "text": "We present the case of a patient with a left frontal glioblastoma with primitive neuroectodermal tumor features and hypermutated genotype in the setting of a POLE germline alteration"}, {"pubmed": 27807100, "text": "Hypermutation and elevated neoantigen count in glioblastoma occurred in a patient harboring a germline POLE mutation and are associated with a clinical and antitumor immune response to PD-1 blockade"}, {"pubmed": 27894751, "text": "POLE ultra-mutated endometrial-carcinomas are heavily infiltrated with CD4+/CD8+ TIL, overexpress PD-1 immune-check-point, and have a better prognosis when compared to other molecular subtypes of endometrial-carcinomas patients. POLE-mutated tumor-cell lines are resistant to platinum-chemotherapy in-vitro suggesting that the better prognosis of POLE-patients is not secondary to a higher sensitivity to ch"}, {"pubmed": 28034776, "text": "Mutational analysis of hypermutation-related POLE gene in acute leukemias and lymphomas."}, {"pubmed": 28061006, "text": "Tumors with POLE EDMs had the most favorable prognosis, and those with p53 abn the worst prognosis, and separation of the 2 middle survival curves (p53 wt and MMR-D) was observed"}, {"pubmed": 28199690, "text": "Human CTF18-RFC clamp-loader complexed with non-synthesising POLE efficiently loads the PCNA sliding clamp."}, {"pubmed": 28218421, "text": "Frameshift mutation in POLE gene is associated with mismatch repair-deficiency and Lynch syndrome."}, {"pubmed": 28404093, "text": "Meta-analysis found that POLE proofreading domain mutations identify a subset of immunogenic colorectal cancers with excellent prognosis."}, {"pubmed": 28423643, "text": "This is the first study to functionally analyze a POLE genetic variant outside the exonuclease domain and widens the spectrum of genetic changes in this DNA polymerase that could lead to colorectal cancer predisposition."}, {"pubmed": 28465371, "text": "The basic biochemical mechanisms leading to a unique phenotype in POLE deficiency as well as challenges faced with interpreting the genomic profiling of tumors in this important subset of patients and the potential clinical implications will be discussed here"}, {"pubmed": 28498284, "text": "POLE-mutated undifferentiated and dedifferentiated endometrial carcinomas were more frequently stage I tumors than similar carcinomas lacking exonuclease domain mutations (7/9; 78% vs. 3/12; 25%; P=0.023) and patients had significantly better outcome (disease-specific survival) than those without POLE exonuclease domain mutations (P=0.02)"}, {"pubmed": 28512192, "text": "Mutation in DNA Polymerase II gene is associated with MMR deficiency in cancer."}, {"pubmed": 28805995, "text": "Germline PMS2 and somatic POLE exonuclease mutations cause hypermutability of the leading DNA strand in biallelic mismatch repair deficiency syndrome brain tumours"}, {"pubmed": 29072370, "text": "Case Reports: POLE heterozygous mutations were found in two colorectal adenocarcinomas."}, {"pubmed": 29320758, "text": "The POLE mutations have in selecting for mutations of the beta2 microglobulin (B2M) gene involved in antigen presentation."}, {"pubmed": 29488881, "text": "These results strongly suggest that concomitant suppression of mismatch repair, a hallmark of colorectal and other aggressive cancers, is a critical force for driving the explosive mutagenesis seen in tumors expressing exonuclease-deficient Pol epsilon."}, {"pubmed": 29559562, "text": "The favorable prognosis of POLE-mutant cancers cannot be explained by increased sensitivity to currently used adjuvant treatments. These results support studies exploring minimization of adjuvant therapy for early-stage POLE-mutant cancers, including endometrial and colorectal cancers."}, {"pubmed": 29572003, "text": "POLE mutation represents an uncommon phenotype in non-small-cell lung cancer; may represent a candidate biomarker for response to immunotherapy"}, {"pubmed": 29650000, "text": "Study demonstrated the distinct prognostic values of POLE mutation and PD-L1 expression in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC). Importantly, the combination of POLE mutation and PD-L1 expression as a favorable indicator for improved OS of LUAD patients and the activation of antitumor immune system."}, {"pubmed": 29659608, "text": "Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability"}, {"pubmed": 29754823, "text": "Mutation in DNA Polymerase epsilon is associated with growth disorders."}, {"pubmed": 29880869, "text": "During the period prior to occurrence of the aberrant POLE, bare accumulation of mutations in cancer-related genes was observed, whereas PTEN was highly mutated in conjunction with or subsequent to the event, suggesting that POLE and PTEN mutations were responsible for the development of POLE-mutated tumours."}, {"pubmed": 29895728, "text": "These findings support a role for E2 beyond E1 recruitment in human papillomavirus 11 DNA replication, and further implicate cellular pol epsilon in viral DNA replication."}, {"pubmed": 30194485, "text": "Data suggest that DNA polymerase epsilon catalytic subunit (POLE) mutation does not serve as a relevant biomarker and should not be tested on a regular basis in pancreatic ductal adenocarcinoma (PDAC)."}, {"pubmed": 30362666, "text": "Prominent POLE-deficient somatic mutational signatures were seen in the colorectal cancers, but in contrast, a mutational signature typical of concomitant tumoral loss of POLE and mismatch-repair function (POLE-exo(*) /MSI) was noted in the breast cancer."}, {"pubmed": 30368636, "text": "Study reports a family with an autosomal dominant inheritance of proofreading-associated polyposis syndrome due to a c.1089C>A; p.Asn363Lys mutation in the proofreading exonuclease domain of POLE. Ten patients presenting a history of colorectal tumors and three patients with polyposis are indexed in this family. Three carriers presented glioblastoma."}, {"pubmed": 30448219, "text": "We found a high frequency of POLE mutations in synchronous endometrial and ovarian carcinoma."}, {"pubmed": 30503519, "text": "Establish POLE as a second gene in which mutations cause IMAGe syndrome."}, {"pubmed": 30917185, "text": "Study demonstrates that POLE-mutated endometrial cancer is significantly associated with previously unknown clinicopathologic characteristics. The outcome in POLE-mutated tumours was excellent in cases with hotspot mutations."}, {"pubmed": 31240875, "text": "Clinicopathological and mutational analyses of colorectal cancer with mutations in the POLE gene."}, {"pubmed": 31335355, "text": "POLE mutations are not commonly found in ovarian clear cell carcinomas with abnormal p53 expression."}, {"pubmed": 31479159, "text": "Morphological, immunophenotypical and molecular features of hypermutation in colorectal carcinomas with mutations in DNA polymerase epsilon (POLE)."}, {"pubmed": 31673068, "text": "Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population."}, {"pubmed": 31757464, "text": "Of the 451 EECs sequenced, 23 had a POLE EDM (5%): 20 primary and 3 recurrent tumors sequenced. Nineteen cases (83%) were stage I/II and 4 (17%) were stages III/IV. Thirteen EECs (57%) were of FIGO grades 1/2, 10 (43%) grade 3."}, {"pubmed": 31864301, "text": "results suggested comprehensive consideration of the POLE mutations, expression of AMF/PGI and AMFR/gp78 may provide a more feasible and effective approach for the treatment of endometrial cancer, which might improve the prognosis"}, {"pubmed": 32012149, "text": "Study curated somatic mutation calls from 7,345 colorectal cancer samples from published studies and publicly available databases and found that different POLE mutants exhibit distinct mutation spectrum with significantly higher relative frequency of C>T mutations in POLE V411L mutants. Analysis showed strong association of the TP53 R213* mutation specifically with POLE P286R mutants."}, {"pubmed": 32080141, "text": "Systematic review assessing 179 endometrial cancer patients with POLE exonuclease domain mutations indicated a favorable progression-free survival in POLE-mutant patients and the overall survival was greater in patients with POLE-mutantions"}, {"pubmed": 32205482, "text": "In a subset of endometrial carcinomas with a serous component POLE exonuclease domain mutations and DNA mismatch repair deficiency are associated with superior outcomes."}, {"pubmed": 32415104, "text": "DNA polymerase epsilon relies on a unique domain for efficient replisome assembly and strand synthesis."}, {"pubmed": 32424176, "text": "Genetic, structural, and functional characterization of POLE polymerase proofreading variants allows cancer risk prediction."}, {"pubmed": 32433714, "text": "Study demonstrated that high POLE expression associated with increased cell proliferation, somatic hypermutation, and elevated endogenous retroviruses (REV) expression produced a favorable prognosis in patients with non-small cell lung cancer (NSCLC). High POLE expression could enhance recruitment of tumor-infiltrating lymphocytes through hypermutation and/or ERVs rather than effects on cell proliferation."}, {"pubmed": 32497495, "text": "POLE Mutation Spectra Are Shaped by the Mutant Allele Identity, Its Abundance, and Mismatch Repair Status."}, {"pubmed": 32567205, "text": "POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East."}, {"pubmed": 32627883, "text": "Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer."}, {"pubmed": 32699191, "text": "A PoleP286R mouse model of endometrial cancer recapitulates high mutational burden and immunotherapy response."}, {"pubmed": 32792570, "text": "Role of POLE and POLD1 in familial cancer."}, {"pubmed": 32800323, "text": "POLE mutation combined with microcystic, elongated and fragmented (MELF) pattern invasion in endometrial carcinomas might be associated with poor survival in Chinese women."}, {"pubmed": 32859741, "text": "Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer."}, {"pubmed": 33051204, "text": "Kinetic investigation of the polymerase and exonuclease activities of human DNA polymerase epsilon holoenzyme."}, {"pubmed": 33125191, "text": "Ultra-mutated colorectal cancer patients with POLE driver mutations exhibit distinct clinical patterns."}, {"pubmed": 33399963, "text": "Endometrial cancer with a POLE mutation progresses frequently through the type I pathway despite its high-grade endometrioid morphology: a cohort study at a single institution in Japan."}, {"pubmed": 33715893, "text": "Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma."}, {"pubmed": 33764464, "text": "Mutagenic mechanisms of cancer-associated DNA polymerase alleles."}, {"pubmed": 34034807, "text": "Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations."}, {"pubmed": 34250404, "text": "Tumor-Infiltrating Lymphocytes, Tumor Mutational Burden, and Genetic Alterations in Microsatellite Unstable, Microsatellite Stable, or Mutant POLE/POLD1 Colon Cancer."}, {"pubmed": 34586735, "text": "POLE/POLD1 mutation in non-exonuclease domain matters for predicting efficacy of immune-checkpoint-inhibitor therapy."}, {"pubmed": 34594041, "text": "Increased somatic mutation burdens in normal human cells due to defective DNA polymerases."}, {"pubmed": 34607897, "text": "Distinct mutational profile and immune microenvironment in microsatellite-unstable and POLE-mutated tumors."}, {"pubmed": 34875656, "text": "PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation."}, {"pubmed": 34907997, "text": "A Multiplex SNaPshot Assay is a Rapid and Cost-Effective Method for Detecting POLE Exonuclease Domain Mutations in Endometrial Carcinoma."}, {"pubmed": 35108036, "text": "Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers."}, {"pubmed": 35139130, "text": "The clinicopathology and survival characteristics of patients with POLE proofreading mutations in endometrial carcinoma: A systematic review and meta-analysis."}, {"pubmed": 35320887, "text": "Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study."}, {"pubmed": 35715491, "text": "Efficient discrimination against RNA-containing primers by human DNA polymerase epsilon."}, {"pubmed": 35780178, "text": "POLE/POLD1 mutation and tumor immunotherapy."}, {"pubmed": 35793867, "text": "Pathological complete response to immune checkpoint inhibitor in patients with colorectal cancer liver metastases harboring POLE exonuclease domain mutation."}, {"pubmed": 35817971, "text": "Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity."}, {"pubmed": 36261579, "text": "The iron-sulfur cluster is essential for DNA binding by human DNA polymerase epsilon."}, {"pubmed": 36314330, "text": "An in silico analysis of the impact of POLE mutations on cladribine docking."}, {"pubmed": 36727290, "text": "Cytopathological features associated with POLE mutation in endometrial cancer."}, {"pubmed": 37891003, "text": "Exploring the basis of heterogeneity of cancer aggressiveness among the mutated POLE variants."}, {"pubmed": 37990341, "text": "Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases epsilon and delta in glioma families."}, {"pubmed": 38148087, "text": "Cervical Cytology Preserves Histologically Detected Surface Epithelial Slackening, Unique to the POLE Mutation-subtype in Endometrial Cancer."}, {"pubmed": 38219146, "text": "DNA polymerase epsilon and delta variants drive mutagenesis in polypurine tracts in human tumors."}, {"pubmed": 38231514, "text": "Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial Cancer."}, {"pubmed": 38238314, "text": "The P286R mutation of DNA polymerase epsilon activates cancer-cell-intrinsic immunity and suppresses endometrial tumorigenesis via the cGAS-STING pathway."}, {"pubmed": 38282550, "text": "Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity."}], "genomic_pos": {"chr": "12", "end": 132687376, "ensemblgene": "ENSG00000177084", "start": 132623753, "strand": -1}, "genomic_pos_hg19": {"chr": "12", "end": 133263951, "start": 133200348, "strand": -1}, "go": {"BP": [{"evidence": "IMP", "gocategory": "BP", "id": "GO:0000082", "pubmed": 16762037, "qualifier": "involved_in", "term": "G1/S transition of mitotic cell cycle"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0000278", "qualifier": "involved_in", "term": "mitotic cell cycle"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0000731", "pubmed": 1730053, "qualifier": "involved_in", "term": "DNA synthesis involved in DNA repair"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006260", "pubmed": 16762037, "qualifier": "involved_in", "term": "DNA replication"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006261", "pubmed": 33051204, "qualifier": "involved_in", "term": "DNA-templated DNA replication"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006272", "qualifier": "involved_in", "term": "leading strand elongation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006287", "qualifier": "involved_in", "term": "base-excision repair, gap-filling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006287", "pubmed": 10559260, "qualifier": "involved_in", "term": "base-excision repair, gap-filling"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006297", "qualifier": "involved_in", "term": "nucleotide-excision repair, DNA gap filling"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0006297", "pubmed": 20227374, "qualifier": "involved_in", "term": "nucleotide-excision repair, DNA gap filling"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0045004", "qualifier": "involved_in", "term": "DNA replication proofreading"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048568", "qualifier": "involved_in", "term": "embryonic organ development"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 16762037, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0008622", "qualifier": "part_of", "term": "epsilon DNA polymerase complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0008622", "pubmed": [10801849, 22465957], "qualifier": "part_of", "term": "epsilon DNA polymerase complex"}, {"evidence": "IPI", "gocategory": "CC", "id": "GO:0008622", "pubmed": 10801849, "qualifier": "part_of", "term": "epsilon DNA polymerase complex"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0000166", "qualifier": "enables", "term": "nucleotide binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0003677", "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003677", "pubmed": 16762037, "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003682", "pubmed": 16762037, "qualifier": "enables", "term": "chromatin binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0003887", "qualifier": "enables", "term": "DNA-directed DNA polymerase activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0003887", "pubmed": 16762037, "qualifier": "enables", "term": "DNA-directed DNA polymerase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [10801849, 28514442, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0008270", "qualifier": "enables", "term": "zinc ion binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008310", "qualifier": "enables", "term": "single-stranded DNA 3'-5' DNA exonuclease activity"}, {"category": "MF", "evidence": "IEA", "id": "GO:0051539", "qualifier": "enables", "term": "4 iron, 4 sulfur cluster binding"}]}, "homologene": {"genes": [[3702, 817254], [3702, 837346], [4530, 4329458], [4896, 2540627], [4932, 855459], [5141, 3872087], [6239, 173368], [7165, 1275917], [7227, 42758], [7955, 553405], [8364, 100498309], [9031, 416997], [9598, 467165], [9606, 5426], [9615, 486223], [9913, 785457], [10090, 18973], [10116, 304573], [28985, 2892428], [33169, 4622494], [318829, 2677352]], "id": 4539}, "interpro": [{"desc": "DNA-directed DNA polymerase, family B, exonuclease domain", "id": "IPR006133", "short_desc": "DNA-dir_DNA_pol_B_exonuc"}, {"desc": "DNA-directed DNA polymerase, family B, multifunctional domain", "id": "IPR006134", "short_desc": "DNA-dir_DNA_pol_B_multi_dom"}, {"desc": "DNA-directed DNA polymerase, family B", "id": "IPR006172", "short_desc": "DNA-dir_DNA_pol_B"}, {"desc": "Ribonuclease H-like superfamily", "id": "IPR012337", "short_desc": "RNaseH-like_sf"}, {"desc": "DNA polymerase epsilon, catalytic subunit A, C-terminal", "id": "IPR013697", "short_desc": "DNA_pol_e_suA_C"}, {"desc": "DNA polymerase, palm domain superfamily", "id": "IPR023211", "short_desc": "DNA_pol_palm_dom_sf"}, {"desc": "DNA polymerase epsilon catalytic subunit", "id": "IPR029703", "short_desc": "POL2"}, {"desc": "Ribonuclease H superfamily", "id": "IPR036397", "short_desc": "RNaseH_sf"}, {"desc": "DNA polymerase family B, thumb domain", "id": "IPR042087", "short_desc": "DNA_pol_B_thumb"}, {"desc": "DNA/RNA polymerase superfamily", "id": "IPR043502", "short_desc": "DNA/RNA_pol_sf"}], "ipi": ["IPI00744598", "IPI00790334", "IPI00939602", "IPI00940894", "IPI01012998", "IPI01013454", "IPI01013828"], "map_location": "12q24.33", "name": "DNA polymerase epsilon, catalytic subunit", "other_names": ["3'-5' exodeoxyribonuclease", "DNA polymerase II subunit A", "DNA polymerase epsilon catalytic subunit A", "DNA polymerase epsilon catalytic subunit protein", "polymerase (DNA directed), epsilon, catalytic subunit", "polymerase (DNA) epsilon, catalytic subunit"], "pantherdb": {"HGNC": "9177", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "1196391", "ortholog_type": "LDO", "panther_family": "PTHR10670", "taxid": 10090, "uniprot_kb": "Q9WVF7"}, {"RGD": "1594540", "ortholog_type": "LDO", "panther_family": "PTHR10670", "taxid": 10116, "uniprot_kb": "D3Z8X4"}, {"Ensembl": "ENSGALG00000007665", "ortholog_type": "LDO", "panther_family": "PTHR10670", "taxid": 9031, "uniprot_kb": "E1C5P2"}, {"ZFIN": "ZDB-GENE-070705-557", "ortholog_type": "LDO", "panther_family": "PTHR10670", "taxid": 7955, "uniprot_kb": "B0V351"}, {"WormBase": "WBGene00009368", "ortholog_type": "LDO", "panther_family": "PTHR10670", "taxid": 6239, "uniprot_kb": "O62218"}, {"FlyBase": "FBgn0264326", "ortholog_type": "LDO", "panther_family": "PTHR10670", "taxid": 7227, "uniprot_kb": "Q9VCN1"}, {"SGD": "S000005206", "ortholog_type": "LDO", "panther_family": "PTHR10670", "taxid": 4932, "uniprot_kb": "P21951"}, {"PomBase": "SPBC25H2.13c", "ortholog_type": "LDO", "panther_family": "PTHR10670", "taxid": 4896, "uniprot_kb": "P87154"}, {"dictyBase": "DDB_G0283189", "ortholog_type": "LDO", "panther_family": "PTHR10670", "taxid": 352472, "uniprot_kb": "Q54RD4"}, {"TAIR": "2059314", "ortholog_type": "O", "panther_family": "PTHR10670", "taxid": 3702, "uniprot_kb": "F4IFN6"}, {"TAIR": "2199973", "ortholog_type": "LDO", "panther_family": "PTHR10670", "taxid": 3702, "uniprot_kb": "F4HW04"}], "uniprot_kb": "Q07864"}, "pathway": {"kegg": [{"id": "hsa03030", "name": "DNA replication - Homo sapiens (human)"}, {"id": "hsa03410", "name": "Base excision repair - Homo sapiens (human)"}, {"id": "hsa03420", "name": "Nucleotide excision repair - Homo sapiens (human)"}], "reactome": [{"id": "R-HSA-110313", "name": "Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template"}, {"id": "R-HSA-110314", "name": "Recognition of DNA damage by PCNA-containing replication complex"}, {"id": "R-HSA-110373", "name": "Resolution of AP sites via the multiple-nucleotide patch replacement pathway"}, {"id": "R-HSA-1640170", "name": "Cell Cycle"}, {"id": "R-HSA-453279", "name": "Mitotic G1 phase and G1/S transition"}, {"id": "R-HSA-5651801", "name": "PCNA-Dependent Long Patch Base Excision Repair"}, {"id": "R-HSA-5656169", "name": "Termination of translesion DNA synthesis"}, {"id": "R-HSA-5685942", "name": "HDR through Homologous Recombination (HRR)"}, {"id": "R-HSA-5693532", "name": "DNA Double-Strand Break Repair"}, {"id": "R-HSA-5693538", "name": "Homology Directed Repair"}, {"id": "R-HSA-5693567", "name": "HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)"}, {"id": "R-HSA-5696397", "name": "Gap-filling DNA repair synthesis and ligation in GG-NER"}, {"id": "R-HSA-5696398", "name": "Nucleotide Excision Repair"}, {"id": "R-HSA-5696399", "name": "Global Genome Nucleotide Excision Repair (GG-NER)"}, {"id": "R-HSA-5696400", "name": "Dual Incision in GG-NER"}, {"id": "R-HSA-6781827", "name": "Transcription-Coupled Nucleotide Excision Repair (TC-NER)"}, {"id": "R-HSA-6782135", "name": "Dual incision in TC-NER"}, {"id": "R-HSA-6782210", "name": "Gap-filling DNA repair synthesis and ligation in TC-NER"}, {"id": "R-HSA-68952", "name": "DNA replication initiation"}, {"id": "R-HSA-68962", "name": "Activation of the pre-replicative complex"}, {"id": "R-HSA-69002", "name": "DNA Replication Pre-Initiation"}, {"id": "R-HSA-69206", "name": "G1/S Transition"}, {"id": "R-HSA-69239", "name": "Synthesis of DNA"}, {"id": "R-HSA-69242", "name": "S Phase"}, {"id": "R-HSA-69278", "name": "Cell Cycle, Mitotic"}, {"id": "R-HSA-69306", "name": "DNA Replication"}, {"id": "R-HSA-73884", "name": "Base Excision Repair"}, {"id": "R-HSA-73893", "name": "DNA Damage Bypass"}, {"id": "R-HSA-73894", "name": "DNA Repair"}, {"id": "R-HSA-73933", "name": "Resolution of Abasic Sites (AP sites)"}], "smpdb": {"id": "SMP00478", "name": "Nucleotide Excision Repair "}, "wikipathways": [{"id": "WP2446", "name": "Retinoblastoma gene in cancer"}, {"id": "WP4022", "name": "Pyrimidine metabolism"}, {"id": "WP45", "name": "G1 to S cell cycle control"}, {"id": "WP466", "name": "DNA Replication"}, {"id": "WP4752", "name": "Base Excision Repair"}, {"id": "WP4753", "name": "Nucleotide Excision Repair"}, {"id": "WP4946", "name": "DNA Repair Pathways Full Network"}, {"id": "WP531", "name": "DNA Mismatch Repair"}]}, "pdb": ["5VBN", "7PFO", "7PLO"], "pfam": ["PF00136", "PF03104", "PF08490"], "pharmgkb": "PA277", "pharos": {"target_id": 10984, "tdl": "Tclin"}, "pir": "G02434", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF254423", "relationship": "is"}, {"id": "GNF254424", "relationship": "is"}, {"id": "GNF254425", "relationship": "is"}, {"id": "GNF254426", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF087646", "relationship": "is"}, {"id": "GNF087647", "relationship": "is"}, {"id": "GNF087648", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF052474", "relationship": "is"}, {"id": "GNF057245", "relationship": "is"}, {"id": "GNF072291", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF064567", "relationship": "is"}, {"id": "GNF064568", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF017874", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF107092", "relationship": "is"}, {"id": "GNF146738", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000012.12", "NC_060936.1", "NG_033840.1"], "protein": ["NP_006222.2", "XP_011533097.1", "XP_011533099.1", "XP_011533101.1", "XP_011533104.1", "XP_047284974.1", "XP_054228285.1", "XP_054228286.1", "XP_054228287.1", "XP_054228288.1", "XP_054228289.1"], "rna": ["NM_006231.4", "XM_011534795.4", "XM_011534797.4", "XM_011534799.3", "XM_011534802.4", "XM_047429018.1", "XM_054372310.1", "XM_054372311.1", "XM_054372312.1", "XM_054372313.1", "XM_054372314.1", "XR_008488621.1", "XR_941395.3"], "translation": [{"protein": "XP_054228288.1", "rna": "XM_054372313.1"}, {"protein": "XP_054228285.1", "rna": "XM_054372310.1"}, {"protein": "XP_011533099.1", "rna": "XM_011534797.4"}, {"protein": "NP_006222.2", "rna": "NM_006231.4"}, {"protein": "XP_054228286.1", "rna": "XM_054372311.1"}, {"protein": "XP_011533101.1", "rna": "XM_011534799.3"}, {"protein": "XP_011533097.1", "rna": "XM_011534795.4"}, {"protein": "XP_054228289.1", "rna": "XM_054372314.1"}, {"protein": "XP_054228287.1", "rna": "XM_054372312.1"}, {"protein": "XP_047284974.1", "rna": "XM_047429018.1"}, {"protein": "XP_011533104.1", "rna": "XM_011534802.4"}]}, "reporter": {"HG-U133_Plus_2": "216026_s_at", "HG-U95Av2": ["1726_at", "40450_at", "40451_at"], "HTA-2_0": "TC12002153.hg.1", "HuEx-1_0": "3479181", "HuGene-1_1": "7967736", "HuGene-2_1": "16772625"}, "retired": 80252, "summary": "This gene encodes the catalytic subunit of DNA polymerase epsilon. The enzyme is involved in DNA repair and chromosomal DNA replication. Mutations in this gene have been associated with colorectal cancer 12 and facial dysmorphism, immunodeficiency, livedo, and short stature. [provided by RefSeq, Sep 2013].", "symbol": "POLE", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1418729"}, "unigene": "Hs.524871", "uniprot": {"Swiss-Prot": "Q07864", "TrEMBL": ["A0A8V8TQW1", "A0A087WW42", "A0A8V8TQH1", "F5H1D6", "A0A5F9ZHD6", "F5H7E4", "A0A5F9ZI42", "A0A087WX51"]}, "wikipedia": {"url_stub": "POLE (enzyme)"}}